Singh U V, Udupa N
Department of Pharmaceutics, College of Pharmaceutical Sciences, Kasturba Medical College, Manipal, India.
Pharm Acta Helv. 1997 Jun;72(3):165-73. doi: 10.1016/s0031-6865(97)00013-7.
Methotrexate (MTX) loaded poly (lactic-co-glycolic) acid (PLGA) microspheres were prepared by emulsion solvent evaporation technique. The mean diameter of the microspheres was affected by the type of emulsion stabilizer, polymer concentration, aqueous and organic phase volume and stirring speed. The in vitro release was triphasic and was dependent on copolymer composition and molecular weight of the polymer. Antitumor efficacy in Sarcoma-180 tumor bearing mice exhibited increased volume doubling time (18 +/- 2.7 days) compared to plain subcutaneous injection of methotrexate (8 +/- 0.7 days). Preliminary pharmacokinetic studies following subcutaneous administration of MTX loaded PLGA microspheres illustrated the controlled release of the drug. The studies demonstrated the feasibility of employing PLGA as an effective carrier for antineoplastic drug like methotrexate.
采用乳化溶剂蒸发技术制备了负载甲氨蝶呤(MTX)的聚乳酸-乙醇酸共聚物(PLGA)微球。微球的平均直径受乳化稳定剂类型、聚合物浓度、水相和有机相体积以及搅拌速度的影响。体外释放呈三相,且取决于共聚物组成和聚合物的分子量。与甲氨蝶呤皮下注射(8±0.7天)相比,在荷肉瘤-180小鼠中的抗肿瘤疗效表现为体积倍增时间延长(18±2.7天)。皮下注射负载MTX的PLGA微球后的初步药代动力学研究表明该药物具有控释特性。这些研究证明了将PLGA用作甲氨蝶呤等抗肿瘤药物有效载体的可行性。